Alzheimer’s disease afflicts nearly half of the people in the U.S. who are over 85, but new research is giving new hope.
According to an article in Psych Central, researchers recently found that a protein involved in Alzheimer’s binds to cholesterol. That means new therapies for the disease could be on the way.
The protein involved with Alzheimer’s, called an amyloid-beta, clumps together and that kills neurons, which then causes memory loss and dementia.
The new research at Vanderbilt University has found that one of the pieces that make up amyloid-beta may be binding to cholesterol.
Researchers have believed for a long time that there is a connection to cholesterol and Alzheimer’s, and now they may understand the mechanisms better.
The hope is now that they can come up with a way to keep the cholesterol from binding with the precursor-protein, stopping from amyloid-beta in the first place.
This is hopeful news to all the seniors and their families currently coping with Alzheimer’s disease.